The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 6, 1999, Pages 731-740

  Van Herwaarden, M A ^b   Samsom, M ^c   Van Nispen, C H M ^a   Mulder, P G H ^c   Smout, A J P M ^c  

^a U Gene Clinical Pharmacology Unit   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; LANSOPRAZOLE; OMEPRAZOLE; RANITIDINE BISMUTH CITRATE; UREASE;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PH;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; RANITIDINE;

EID: 0033036686     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00531.x     Document Type: Article

References (45)

1. 1 Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311-14.
2. 2 Forman D, Sitas F, Newell DG, et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46: 608-11.
3. 3 Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
4. 4 Doglioni C, Wotherspoon AC, Moschini A, de Boni M. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992; 339: 834-5.
5. 5 Gledhill T, Leicester RJ, Addis B, et al. Epidemic hypochlorhydria. Br Med J 1985; 290: 1383-6.
6. 6 Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192-9.
7. 7 Sobala GM, Crabtree JE, Dixon MF, et al. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 1991; 32: 1415-18.
8. 8 Goldschmiedt M, Barnett CC, Schwarz BE, Karnes WE, Redfern JS, Feldman M. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology 1991; 101: 977-90.
9. 9 Peterson WL, Barnett CC, Evens DJ, et al. Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am J Gastroenterol 1993; 88: 2038-43.
10. 10 Gutierrez 0, Melo M, Segura AM, Angel A, Genta RM, Graham DY. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 1997; 32: 664-8.
11. 11 Taguchi Y. Kaito M, Gabazza EC, et al. Helicobacter pylori inhibits the secretory activity of gastric parietal cells in patients with chronic gastritis. An ultrastructural study. Scand J Gastroenterol 1997; 32: 656-63.
12. 12 El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McKoll KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681-91.
13. 13 El-Omar E, Penman I, Dorrian CA, Ardill JK. McKoll KE. Eradicating Helicobacter pylori infections lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993; 34: 1060-5.
14. 14 Katelaris PH, Seow F, Lin BP, Napoli J, Ngu MC, Jones DB. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 1993; 34: 1032-7.
15. 15 Smith JT, Pounder RE, Nwokolo CU, et al. Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 1990; 31: 522-5.
16. 16 Wagner S, Gladziwa U, Haruma K, Varrentrapp M, Gebel M. Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcer. Gut 1992; 33: 1024-8.
17. 17 Verdú EF, Armstrong D, Fraser R, et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995; 36: 539-43.
18. 18 Verdú EF, Armstrong D, Idström J-P, et al. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995; 37: 743-8.
19. 19 Walsh JH, Richardson CT, Fordtran JS. pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 1975; 55:462-8.
20. 20 Feldman M, Richardson CT. Total 24-hour gastric acid secretion in patients with duodenal ulcer. Gastroenterology 1986; 90; 540-4.
21. 21 Blair III AJ, Feldman M, Barnett C, Walsh JH, Richardson CT. Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects. J Clin Invest 1987; 79: 582-7.
22. 22 Merki HS, Fimmel CJ, Walt RP, Harre K, Rohmel J. Witzel L. Pattern of 24 hour intragastric acidity in active duodenal ulcer disease and in healthy controls. Gut 1988; 29: 1583-7.
23. 23 Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet, 1989; i: 1167-8.
24. 24 Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 1993; 34: 888-92.
25. 25 McColl KEL, Fullarton GM, Chittajalu R, et al. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 1991; 26: 339-46.
26. 26 Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110: 725-32.
27. 27 Labenz J, Tillenburg B, Peitz U, et al. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer. Gut 1997; 41: 33-6.
28. 28 Vlasblom V, Fellinger HW, Breumelhof R, Smout AJPM. Effects of a new effervescent cimetidine formulation on gastric acidity in healthy subjects. Neth J Med 1991; 38: 147-52.
29. 29 Koop H, Kuly S, Flüg M, et al. Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects. Eur J Gastroenterol Hepatol 1996; 8: 915-18.
30. 30 Verdú EF, Armstrong D, Idström J, et al. Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis. Scand J Gastroenterol 1996; 31: 1151-6.
31. 31 Beil W, Birkholz C, Wagner S, Sewing K-F. Interaction of Helicobacter pylori and its fatty acids with parietal cells and gastric H+/K+-ATPase. Gut 1994; 35: 1176-80.
32. 32 Cave DR, Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet 1989; ii: 187-9.
33. 33 Huang LL, Cave DR, Kane AV. Purification and characterization of an acid inhibitory protein from Helicobacter pylori. Gastroenterology 1995; 108: A839(Abstract).
34. 34 Bercik P, Verdu EF, Armstrong D, et al. H. pylori related increase in omeprazole (OME) effect is associated with ammonia production. Gastroenterology 1997; 110: 64.
35. 2-receptor anatagonists with lansoprazole, a new H+/K+-ATPase inhibitor: a controlled, double blind study. Am J Gastroenterol 1993; 88: 1212-17.
36. 36 Jones RH, Baxter G. Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice. Aliment Pharmacol Ther 1997; 11: 541-6.
37. 37 Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 1018-22.
38. 38 Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut 1997; 41: 740-7.
39. 39 Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975; 2: 58-60.
40. 40 Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19(Suppl. 1): S37-41.
41. 41 Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985; 35: 175-7.
42. 42 The European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Repor. Gut 1997; 41: 8-13.
43. 43 Labenz J, Blum AL, Bayerdorfer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-7.
44. 44 Werdmuller BFM, Loffeld RJLF. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 1997; 42: 103-5.
45. 45 Hackelsberger A, Schultze V, Gunther T, et al. H. pylori prevalence in reflux esophagitis - a case-control study. Gastroenterology 1997; 112: A137(Abstract).